Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00941304 · ClinicalTrials.gov registry record · Phase 2
Study of Buprenorphine HCl Buccal Film in the Treatment of Dental Pain
A Phase 2 study, sponsored by BioDelivery Sciences International.
- Completed
- Registry status
- Phase 2
- Development phase
- 153
- Enrollment target
NCT00941304 is a Phase 2 study that has completed, run by BioDelivery Sciences International. The registered enrollment target is 153 participants.
The verdict
NCT00941304, a Phase 2 study, has completed, sponsored by BioDelivery Sciences International.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 153 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the activity of buprenorphine hydrochloride (HCl) buccal film in the treatment of dental pain.
Interventions
- DRUG Oxycodone
- DRUG Buprenorphine
- DRUG Placebo Film
- DRUG Placebo Capsule
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 153 participants |
| Start Date | 2009-08 |
| Est. Completion | 2009-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00941304
The ClinicalTrials.gov registry entry for NCT00941304 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 153 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is BioDelivery Sciences International, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Oxycodone is the first listed.
NCT00941304 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00941304 about?
NCT00941304 is a clinical study titled "Study of Buprenorphine HCl Buccal Film in the Treatment of Dental Pain". The purpose of this study is to assess the activity of buprenorphine hydrochloride (HCl) buccal film in the treatment of dental pain.
What is the current status of trial NCT00941304?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 153 participants. The study started on 2009-08. Estimated completion is 2009-11.
What interventions are being tested in trial NCT00941304?
The interventions under investigation include: Oxycodone (DRUG), Buprenorphine (DRUG), Placebo Film (DRUG), Placebo Capsule (DRUG).
Who is sponsoring clinical trial NCT00941304?
This trial is sponsored by BioDelivery Sciences International, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.